Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,684 | -102,937 | -110,482 | -79,786 | -37,215 |
| Depreciation Amortization | 1,701 | 4,963 | 3,571 | 2,388 | 1,224 |
| Income taxes - deferred | N/A | 2,093 | -1,204 | -741 | N/A |
| Accounts receivable | 7,114 | -9,799 | 250 | -205 | 6 |
| Accounts payable and accrued liabilities | 745 | 4,547 | 1,822 | 5,610 | 3,814 |
| Other Working Capital | -507 | -5,862 | -42 | -212 | 2,302 |
| Other Operating Activity | -2,091 | 4,251 | 25,842 | 17,433 | 1,788 |
| Operating Cash Flow | $-24,722 | $-102,744 | $-80,243 | $-55,513 | $-28,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -374 | -1,611 | -1,230 | -477 | -327 |
| Purchase Of Investment | -79,033 | -232,343 | -128,984 | -105,328 | -33,657 |
| Sale Of Investment | 23,834 | 121,315 | 95,315 | 73,615 | 41,818 |
| Investing Cash Flow | $-55,573 | $-112,639 | $-34,899 | $-32,190 | $7,834 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,049 | 209,524 | 35,918 | 35,659 | 580 |
| Other Financing Activity | -286 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,763 | $209,524 | $35,918 | $35,659 | $580 |
| Exchange Rate Effect | 308 | 157 | 320 | 84 | 9 |
| Beginning Cash Position | 183,798 | 189,500 | 189,500 | 189,500 | 189,500 |
| End Cash Position | 105,574 | 183,798 | 110,596 | 137,540 | 169,842 |
| Net Cash Flow | $-78,224 | $-5,702 | $-78,904 | $-51,960 | $-19,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,722 | -102,744 | -80,243 | -55,513 | -28,081 |
| Capital Expenditure | -374 | -1,878 | -1,497 | -744 | -594 |
| Free Cash Flow | -25,096 | -104,622 | -81,740 | -56,257 | -28,675 |